OncoTrack

Dubbed OncoTrack, the project is being funded for five years with around €27 million, and will involve whole-genome sequencing of the primary tumors of 60 colon cancer patients and matched normal genomes.

OncoTrack, a new international consortium, will seek to generate high-quality genomic and epigenetic data from clinically well-defined colon cancer tumors and their metastases as part of its colon cancer project.